Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PFE, JNJ, NVS, MRK, Medtronic, and represent 24.37% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: Medtronic (+$35.35M), REGN (+$28.09M), La Jolla Pharmaceuticl Com Par (+$15.22M), Acceleron Pharma (+$14.53M), Evolent Health (+$13.51M), ACAD (+$11.93M), Loxo Oncology (+$10.54M), PFE (+$8.62M), Irhythm Technologies Inc Com Added (+$7.87M), NVS (+$7.26M).
- Started 9 new stock positions in Medtronic, Immune Design, Versartis, Irhythm Technologies Inc Com Added, Spring Bk Pharmaceuticals In, Clovis Oncology, CI, Evolent Health, Spark Therapeutics.
- Reduced shares in these 10 stocks: , NBIX (-$28.17M), Teladoc (-$17.89M), Alder Biopharmaceuticals (-$14.83M), ISRG (-$11.42M), Portola Pharmaceuticals (-$10.22M), ARAY (-$9.00M), FOLD (-$8.33M), NVO (-$7.46M), Advaxis (-$6.86M).
- Sold out of its positions in Advaxis, Alder Biopharmaceuticals, ALNY, Avexis, BIIB, CLDX, Corvus Pharmaceuticals, Intersect Ent, Kite Pharma, MOH. NVO, Profound Medical, SHPGY.
- Sectoral Asset Management was a net seller of stock by $12.60M.
- Sectoral Asset Management has $914.42M in assets under management (AUM), growing by 6.79%.
Companies in the Sectoral Asset Management portfolio as of June 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Pfizer (PFE) | 5.16 | 1.41M | +22% | 33.59 |
| Johnson & Johnson (JNJ) | 5.12 | 354048 | +3% | 132.29 |
| Novartis AG (NVS) | 5.11 | 559296 | +18% | 83.47 |
| Merck & Co (MRK) | 5.11 | 729483 | 64.09 | |
| Medtronic | 3.87 | 398360 | NEW | 88.75 |
| Amicus Therapeutics (FOLD) | 3.84 | 3.48M | -19% | 10.07 |
| ABIOMED (ABMD) | 3.59 | 229272 | -12% | 143.30 |
| Regeneron Pharmaceuticals (REGN) | 3.38 | 62898 | +1004% | 491.14 |
| ACADIA Pharmaceuticals (ACAD) | 3.35 | 1.10M | +63% | 27.89 |
| Celgene Corporation (CELG) | 3.32 | 233768 | -14% | 129.87 |
| NuVasive (NUVA) | 3.31 | 393289 | 76.92 | |
| Acadia Healthcare | 3.26 | 603210 | -12% | 49.38 |
| BioMarin Pharmaceutical (BMRN) | 3.11 | 313382 | 90.82 | |
| K2m Group Holdings | 2.74 | 1.03M | +22% | 24.36 |
| Dex (DXCM) | 2.67 | 333341 | -6% | 73.15 |
| Portola Pharmaceuticals | 2.59 | 422143 | -30% | 56.17 |
| Collegium Pharmaceutical Inc Common Stock Usd | 2.47 | 1.81M | +41% | 12.51 |
| Aerie Pharmaceuticals | 2.31 | 402674 | +3% | 52.55 |
| Teva Pharmaceutical Industries (TEVA) | 2.19 | 602279 | -20% | 33.22 |
| Mylan Nv | 2.10 | 495804 | -18% | 38.82 |
| Edwards Lifesciences (EW) | 2.07 | 160380 | -20% | 118.24 |
| Teladoc | 2.06 | 543073 | -48% | 34.70 |
| Acceleron Pharma | 2.01 | 604499 | +378% | 30.39 |
| Loxo Oncology | 1.95 | 221795 | +145% | 80.19 |
| La Jolla Pharmaceuticl Com Par | 1.92 | 589959 | +649% | 29.77 |
| Intuitive Surgical (ISRG) | 1.68 | 16467 | -42% | 935.39 |
| Evolent Health | 1.48 | 532812 | NEW | 25.35 |
| Integra LifeSciences Holdings (IART) | 1.45 | 243998 | +20% | 54.51 |
| Global Blood Therapeutics In | 1.35 | 452781 | +31% | 27.35 |
| Neurocrine Biosciences (NBIX) | 1.20 | 238707 | -71% | 46.00 |
| Neuroderm Ltd F | 1.14 | 350085 | -28% | 29.90 |
| Wright Medical Group Nv | 1.12 | 373622 | -35% | 27.49 |
| Endo International | 1.00 | 820699 | +12% | 11.17 |
| NxStage Medical (NXTM) | 0.96 | 349709 | -30% | 25.07 |
| Envision Healthcare | 0.91 | 133220 | +6% | 62.67 |
| Prothena | 0.89 | 151046 | +7% | 54.12 |
| Irhythm Technologies Inc Com Added | 0.86 | 185170 | NEW | 42.49 |
| Masimo Corporation (MASI) | 0.73 | 73300 | +37% | 91.17 |
| Agios Pharmaceuticals | 0.70 | 123599 | +141% | 51.45 |
| Dbv Technologies S A | 0.70 | 179152 | +34% | 35.71 |
| Spark Therapeutics | 0.66 | 101300 | NEW | 59.74 |
| Momenta Pharmaceuticals (MNTA) | 0.55 | 299400 | -34% | 16.90 |
| Albireo Pharma | 0.43 | 188712 | +833% | 20.60 |
| Ra Pharmaceuticals | 0.37 | 178750 | -20% | 18.74 |
| Clovis Oncology | 0.33 | 31900 | NEW | 93.64 |
| Illumina (ILMN) | 0.32 | 16850 | +48% | 173.53 |
| Accuray Incorporated (ARAY) | 0.31 | 588347 | -76% | 4.75 |
| Incyte Corporation (INCY) | 0.30 | 21845 | +27% | 125.93 |
| CIGNA Corporation (CI) | 0.28 | 15510 | NEW | 167.38 |
| Insmed Inc | 0.27 | 145799 | +31% | 17.16 |
| Versartis | 0.20 | 104757 | NEW | 17.45 |
| Obseva Sa | 0.20 | 212831 | +181% | 8.55 |
| Immune Design | 0.18 | 168300 | NEW | 9.75 |
| Spring Bk Pharmaceuticals In | 0.17 | 112500 | NEW | 13.54 |
| Ptc Therapeutics I | 0.12 | 60735 | -82% | 18.33 |
| Sarepta Therapeutics | 0.11 | 28799 | 33.72 | |
| Sage Therapeutics | 0.11 | 12199 | 79.68 | |
| Dr. Reddy's Laboratories (RDY) | 0.09 | 19065 | -40% | 42.12 |
| Tg Therapeutics | 0.09 | 81266 | -40% | 10.05 |
| Trillium Therapeutics, Inc. Cmn | 0.09 | 183272 | +42% | 4.40 |
| Sierra Oncology | 0.03 | 201660 | 1.17 |
Download CSV 
Past 13F-HR SEC Filings by Sectoral Asset Management
- Sectoral Asset Management 2017 Q1 filed May 15, 2017
- Sectoral Asset Management 2016 Q4 filed Feb. 10, 2017
- Sectoral Asset Management 2016 Q3 filed Nov. 10, 2016
- Sectoral Asset Management 2016 Q2 filed Aug. 12, 2016
- Sectoral Asset Management 2016 Q1 filed May 13, 2016
- Sectoral Asset Management 2015 Q4 filed Feb. 12, 2016
- Sectoral Asset Management 2015 Q3 filed Nov. 13, 2015
- Sectoral Asset Management 2015 Q2 filed Aug. 13, 2015
- Sectoral Asset Management 2015 Q1 filed May 14, 2015
- Sectoral Asset Management 2014 Q4 filed Feb. 13, 2015
- Sectoral Asset Management 2014 Q3 filed Nov. 13, 2014
- Sectoral Asset Management 2014 Q2 filed Aug. 14, 2014
- Sectoral Asset Management 2014 Q1 filed May 14, 2014
- Sectoral Asset Management 2013 Q4 filed Feb. 12, 2014
- Sectoral Asset Management 2013 Q3 filed Nov. 13, 2013
- Sectoral Asset Management 2013 Q2 filed Aug. 12, 2013
- Sectoral Asset Management 2013 Q1 filed May 14, 2013
- Sectoral Asset Management 2012 Q4 filed Feb. 14, 2013
- Sectoral Asset Management 2012 Q3 filed Nov. 13, 2012